| Autor: |
Harvey M. Golomb, Rose Ruchlemer, Gilles Lugassy, Stephanie F. Williams, Aaron Polliack, B Uzielly, Yaron Ilan |
| Rok vydání: |
2016 |
| Předmět: |
|
| Zdroj: |
Leukemialymphoma. 5(4) |
| ISSN: |
1042-8194 |
| Popis: |
During the past 15 years the treatment of Hodgkin's disease (HD) with chemo/radiotherapy has been shown to appreciably improve the long-term prognosis of patients, even those with more advanced disease. In the past it was accepted that the probability of primary relapse 5 years after achieving complete remission (CR) was small and a 5-year disease-free period was sufficient to be considered as a cure. During the past 15 years, however, more data has been published relating to late relapses in these patients after an initial "cure" has been achieved. This report briefly examines our own experience with five patients initially "cured" who relapsed 5 to 11 years after achieving CR and also reviews recent literature on the subject. The phenomenon of late relapse has thus become a more important issue in the management of patients with HD. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
